[go: up one dir, main page]

CN103664674A - Preparation method of multi-substituted fused ring compounds - Google Patents

Preparation method of multi-substituted fused ring compounds Download PDF

Info

Publication number
CN103664674A
CN103664674A CN201310604451.1A CN201310604451A CN103664674A CN 103664674 A CN103664674 A CN 103664674A CN 201310604451 A CN201310604451 A CN 201310604451A CN 103664674 A CN103664674 A CN 103664674A
Authority
CN
China
Prior art keywords
rhodium
preparation
copper
organic solvent
acyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310604451.1A
Other languages
Chinese (zh)
Inventor
包明
于晓强
冯秀娟
张譞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian University of Technology
Original Assignee
Dalian University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian University of Technology filed Critical Dalian University of Technology
Priority to CN201310604451.1A priority Critical patent/CN103664674A/en
Publication of CN103664674A publication Critical patent/CN103664674A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明属于精细化工领域,涉及一种多取代稠环化合物的合成方法改进及相关化学技术。其特征在于:使用N-酰基芳胺和内炔为原料,以铑盐为催化剂,铜盐为氧化剂,在有机溶剂中加热反应,合成一系列多取代稠环化合物。本发明主要是提供一种新的合成多取代稠环化合物的方法,该方法具有方法步骤简单、原料易得、原子经济性高、环境友好等优点。由于多取代稠环化合物是一类重要的骨架结构,在有机半导体材料和发光材料领域有着非常广泛的应用;因此,本发明具有较大的使用价值和社会经济效益。

Figure 201310604451

The invention belongs to the field of fine chemical industry, and relates to an improved synthesis method of multi-substituted condensed ring compounds and related chemical technologies. It is characterized in that: using N-acyl arylamine and internal alkyne as raw materials, using rhodium salt as catalyst, copper salt as oxidant, heating and reacting in an organic solvent to synthesize a series of multi-substituted condensed ring compounds. The present invention mainly provides a new method for synthesizing multi-substituted condensed ring compounds. The method has the advantages of simple method steps, easy availability of raw materials, high atom economy, and environmental friendliness. Since the multi-substituted condensed ring compound is an important skeleton structure, it is widely used in the fields of organic semiconductor materials and light-emitting materials; therefore, the present invention has great use value and social and economic benefits.

Figure 201310604451

Description

一种多取代稠环化合物的制备方法A kind of preparation method of multi-substituted condensed ring compound

技术领域technical field

本发明涉及功能材料的制备方法,尤其是多取代稠环化合物的制备方法。The invention relates to a preparation method of functional materials, especially a preparation method of multi-substituted condensed ring compounds.

背景技术Background technique

多取代稠环化合物是一类重要的骨架结构,在有机半导体材料和发光材料领域有着非常广泛的应用。关于多取代稠环化合物的合成,通常采用如下两种方法:Multi-substituted fused ring compounds are an important class of skeleton structures, which are widely used in the fields of organic semiconductor materials and light-emitting materials. Regarding the synthesis of multi-substituted fused ring compounds, the following two methods are usually adopted:

(1)双官能化的芳香化合物与内炔的成环反应(1) Cyclization of difunctional aromatic compounds with internal alkynes

Figure BDA0000421470320000011
Figure BDA0000421470320000011

该方法的底物价格昂贵、稳定性较差,需要预先制备,原子经济性低[参见:(a)Huang W,ZhouX,Kanno K I,Takahashi T.Org.Lett.2004,6,2429;(b)D,Pérez D,Guitián E,Castedo L.J.Org.Chem.2000,65,6944;(c)

Figure BDA0000421470320000013
D,Pérez D,Guitián E,Castedo L.J.Am.Chem.Soc.1999,121,5827.]。The substrate of this method is expensive, poor in stability, needs to be prepared in advance, and has low atom economy [see: (a) Huang W, ZhouX, Kanno K I, Takahashi T.Org.Lett.2004,6,2429; (b ) D, Pérez D, Guitián E, Castedo LJ Org. Chem. 2000, 65, 6944; (c)
Figure BDA0000421470320000013
D, Pérez D, Guitián E, Castedo LJ Am. Chem. Soc. 1999, 121, 5827.].

(2)单官能化的芳香化合物与内炔的成环反应(2) Cyclization of monofunctional aromatic compounds with internal alkynes

该方法的底物价格昂贵,需要多步合成,且生成的副产物对环境不友好[参见(a)Wu G,Rheingold A L,Feib S L,Heck R F.Organometallics1987,6,1941;(b)Kawasaki S,Satoh T,Miura M,Nomura M.J.Org.Chem.,2003,68,6836;(c)Yasukawa T,Satoh T,Miura M,NomuraM.J.Am.Chem.Soc.2002,124,12680;(d)Ueura K,Satoh T,Miura M.J.Org.Chem.2007,72,5362;(e)Uto T,Shimizu M,Ueura K,Tsurugi H,Satoh T,Miura M.J.Org.Chem.2008,73,298;(f)Fukutani T,Hirano K,Satoh T,Miura M.Org.Lett.,2009,11,5198.]。The substrate of this method is expensive, requires multi-step synthesis, and the by-products generated are not environmentally friendly [see (a) Wu G, Rheingold AL, Feib S L, Heck R F.Organometallics1987,6,1941; (b ) Kawasaki S, Satoh T, Miura M, Nomura M.J.Org.Chem., 2003, 68, 6836; (c) Yasukawa T, Satoh T, Miura M, Nomura M.J.Am.Chem.Soc. 2002, 124, 12680 ;(d) Ueura K, Satoh T, Miura M.J.Org.Chem.2007, 72, 5362; (e) Uto T, Shimizu M, Ueura K, Tsurugi H, Satoh T, Miura M.J.Org.Chem.2008, 73, 298; (f) Fukutani T, Hirano K, Satoh T, Miura M. Org. Lett., 2009, 11, 5198.].

发明目的purpose of invention

本发明的目的是提供一种简单高效、原子经济性高、环境友好的多取代稠环化合物的合成方法。The object of the present invention is to provide a simple, efficient, highly atom-economical and environmentally friendly synthesis method for multi-substituted condensed ring compounds.

发明内容Contents of the invention

本发明以N-酰基芳胺和内炔为原料,以铑盐为催化剂,铜盐为氧化剂,在有机溶剂中加热反应,合成一系列多取代稠环化合物。合成路线如下:The invention uses N-acyl arylamine and internal alkyne as raw materials, uses rhodium salt as catalyst, copper salt as oxidant, heats and reacts in an organic solvent, and synthesizes a series of multi-substituted condensed ring compounds. The synthetic route is as follows:

Figure BDA0000421470320000021
Figure BDA0000421470320000021

在上述合成方法的反应中,所用的铑盐催化剂包括三氯化铑、醋酸铑、二氯(环戊二烯基)合铑(III)二聚体、二氯(五甲基环戊二烯基)合铑(III)二聚体以及三(三苯基膦)氯化铑(I),所述铑盐的加入量为N-酰基芳胺的1mol%-20mol%。In the reaction of the above synthesis method, the rhodium salt catalyst used includes rhodium trichloride, rhodium acetate, dichloro(cyclopentadienyl) rhodium (III) dimer, dichloro(pentamethylcyclopentadiene base) rhodium (III) dimer and tris(triphenylphosphine) rhodium (I) chloride, and the addition amount of the rhodium salt is 1mol%-20mol% of the N-acylarylamine.

在上述合成方法的反应中,所用的铜盐氧化剂包括碘化亚铜、溴化亚铜、氯化亚铜、氧化亚铜、醋酸铜、一水合醋酸铜、氯化铜或氧化铜,所述铜盐的加入量为N-酰基芳胺的20mol%-400mol%。In the reaction of above-mentioned synthetic method, used copper salt oxidant comprises cuprous iodide, cuprous bromide, cuprous chloride, cuprous oxide, copper acetate, cupric acetate monohydrate, cupric chloride or cupric oxide, described The amount of copper salt added is 20mol%-400mol% of the N-acylarylamine.

在上述合成方法的反应中,所用的有机溶剂包括苯、甲苯、1,4-二氧六环、二甲基亚砜、N,N-二甲基甲酰胺、甲醇、乙醇、异丙醇、正丁醇、二氯甲烷、三氯甲烷、正丁醚、四氯化碳、乙酸乙酯、石油醚、甲基叔丁基醚、四氢呋喃、丙酮、乙腈,所述有机溶剂的加入量为N-酰基芳胺重量的10-100倍。In the reaction of the above synthesis method, the organic solvents used include benzene, toluene, 1,4-dioxane, dimethylsulfoxide, N,N-dimethylformamide, methanol, ethanol, isopropanol, Butanol, methylene chloride, chloroform, n-butyl ether, carbon tetrachloride, ethyl acetate, petroleum ether, methyl tert-butyl ether, tetrahydrofuran, acetone, acetonitrile, the addition of the organic solvent is N - 10-100 times the weight of acyl arylamine.

在上述合成方法的反应中,反应温度为50-130℃。In the reaction of the above synthesis method, the reaction temperature is 50-130°C.

附图说明Description of drawings

图1为化合物3a的1H-NMR。Fig. 1 is the 1 H-NMR of compound 3a.

图2为化合物3a的13C-NMR。Fig. 2 is the 13 C-NMR of compound 3a.

图3为化合物3b的1H-NMR。Fig. 3 is the 1 H-NMR of compound 3b.

图4为化合物3b的13C-NMR。Fig. 4 is the 13 C-NMR of compound 3b.

图5为化合物3c的1H-NMR。Fig. 5 is the 1 H-NMR of compound 3c.

图6为化合物3c的13C-NMR。Fig. 6 is the 13 C-NMR of compound 3c.

图7为化合物3d的1H-NMR。Fig. 7 is the 1 H-NMR of compound 3d.

图8为化合物3d的13C-NMR。Fig. 8 is the 13 C-NMR of compound 3d.

图9为化合物3e的1H-NMR。Fig. 9 is the 1 H-NMR of compound 3e.

图10为化合物3e的13C-NMR。Fig. 10 is the 13 C-NMR of compound 3e.

图11为化合物3f的1H-NMR。Fig. 11 is the 1 H-NMR of compound 3f.

图12为化合物3f的13C-NMR。Fig. 12 is the 13 C-NMR of compound 3f.

图13为化合物3g的1H-NMR。Fig. 13 is the 1 H-NMR of compound 3g.

图14为化合物3g的13C-NMR。Fig. 14 is the 13 C-NMR of compound 3g.

图15为化合物3h的1H-NMR。Fig. 15 is the 1 H-NMR of compound 3h.

图16为化合物3h的13C-NMR。Fig. 16 is the 13 C-NMR of compound 3h.

图17为化合物3i的1H-NMR。Fig. 17 is the 1 H-NMR of compound 3i.

图18为化合物3i的13C-NMR。Fig. 18 is the 13 C-NMR of compound 3i.

具体实施方式Detailed ways

下面结合实施例子进一步说明本发明以及本发明方法进行的方式。这些实施例子仅是为了进一步阐述本发明而非本发明的保护仅限于此。The following further describes the present invention and the manner in which the method of the present invention is carried out in conjunction with examples of implementation. These implementation examples are only for further elucidating the present invention rather than limiting the protection of the present invention thereto.

实施例1:N-(5,6,7,8-tetraphenylnaphthalen-1-yl)pivalamide(3a)的合成Example 1: Synthesis of N-(5,6,7,8-tetraphenylnaphthalen-1-yl)pivalamide (3a)

Figure BDA0000421470320000031
Figure BDA0000421470320000031

准确称取N-特戊酰基苯胺(44.3mg,0.25mmol)、氯化铑(2.6mg,0.0125mmol)、二苯乙炔(89.2mg,0.5mmol)、醋酸铜(45.5mg,0.25mmol),并依次加入到25mL的Schlenk瓶中,加入精制过的乙醇(3.0mL),置于50℃油浴中反应8h。反应结束后,减压除去溶剂,使用石油醚/乙酸乙酯作为洗脱剂,硅胶柱分离,N-(5,6,7,8-tetraphenylnaphthalen-1-yl)pivalamide的收率为80%。1H NMR(400MHz,CDCl3)δ7.88(d,J=7.6Hz,1H),7.49(d,J=8.2Hz,1H),7.40(dd,J=7.6,8.2Hz,1H),7.24-7.14(m,11H),6.82-6.74(m,8H),6.64-6.62(m,2H),0.80(s,9H);13C NMR(100MHz,CDCl3)δ177.0,142.3,141.3,140.5,140.3,139.9,139.5,139.0,134.4,134.2,133.6,131.3,131.1,128.5,127.7,127.2,126.7,126.5,125.8,125.6,125.5,125.3,124.9,39.4,27.0;IR(KBr)υ(cm-1)3425,3337,3050,3024,1670,1601,1493,1475,1441,1382,1157,910,778,736,730,698;HRMS(ESI)Calcd for C39H34NO532.2640[M+H]+,found532.2645.Accurately weigh N-pivaloylanilide (44.3mg, 0.25mmol), rhodium chloride (2.6mg, 0.0125mmol), toluene (89.2mg, 0.5mmol), copper acetate (45.5mg, 0.25mmol), and Sequentially added to a 25mL Schlenk bottle, added refined ethanol (3.0mL), and placed in an oil bath at 50°C for 8h. After the reaction, the solvent was removed under reduced pressure, and petroleum ether/ethyl acetate was used as the eluent, and the silica gel column was used for separation. The yield of N-(5,6,7,8-tetraphenylnaphthalen-1-yl)pivalamide was 80%. 1 H NMR (400MHz, CDCl 3 )δ7.88(d, J=7.6Hz, 1H), 7.49(d, J=8.2Hz, 1H), 7.40(dd, J=7.6, 8.2Hz, 1H), 7.24 -7.14(m,11H),6.82-6.74(m,8H),6.64-6.62(m,2H),0.80(s,9H); 13 C NMR(100MHz,CDCl 3 )δ177.0,142.3,141.3,140.5, ( 1 )3425,3337,3050,3024,1670,1601,1493,1475,1441,1382,1157,910,778,736,730,698;HRMS(ESI)Calcd for C 39 H 34 NO532.2640[M+H] + ,found532.2645.

实施例2:N-(5,6,7,8-tetrakis(4-fluorophenyl)naphthalen-1-yl)pivalamide(3b)的合成Example 2: Synthesis of N-(5,6,7,8-tetrakis(4-fluorophenyl)naphthalen-1-yl)pivalamide (3b)

Figure BDA0000421470320000032
Figure BDA0000421470320000032

准确称取N-特戊酰基苯胺(44.3mg,0.25mmol)、醋酸铑(1.1mg,0.0025mmol)、1,2-二(4-氟苯基)乙炔(107.0mg,0.5mmol)、碘化亚铜(47.6mg,0.25mmol),并依次加入到25mL的Schlenk瓶中,加入精制过的环己烷(3.0mL),置于100℃油浴中反应10h。反应结束后,减压除去溶剂,使用石油醚/乙酸乙酯作为洗脱剂,硅胶柱分离,N-(5,6,7,8-tetrakis(4-fluorophenyl)naphthalen-1-yl)pivalamide的收率为63%。1H NMR(400MHz,CDCl3)δ7.82(d,J=6.2Hz,1H),7.48-7.43(m,2H),7.13-7.07(m,5H),6.96-6.89(m,4H),6.68-6.65(m,2H),6.60-6.56(m,6H),0.87(s,9H);13C NMR(100MHz,CDCl3)δ176.9,161.8(d,1JC–F=246.7Hz),161.6(d,1JC–F=244.7Hz),160.7(d,1JC–F=243.9Hz),160.6(d,1JC–F=244.2Hz),140.4,138.9,138.2,137.81,137.78,137.0,136.0,135.82,135.79,135.30,135.27,134.2,134.0,133.5,132.6,132.5,132.4,132.3,132.2,126.2,126.0,125.7,125.64,125.56,115.4(d,2JC–F=21.0Hz),114.8(d,2JC–F=21.1Hz),114.0(2JC–F=16.2Hz),113.9(2JC–F=20.3Hz),39.2,26.9;IR(KBr)υ(cm-1)3444,3321,2956,2917,2848,1659,1604,1509,1478,1380,1224,1157,1093,1015,909,830,816,777,758,734;HRMS(ESI)Calcd for C39H29NONaF4626.2083[M+Na]+,found626.2088.Accurately weigh N-pivaloylanilide (44.3mg, 0.25mmol), rhodium acetate (1.1mg, 0.0025mmol), 1,2-di(4-fluorophenyl)acetylene (107.0mg, 0.5mmol), iodide Cuprous (47.6mg, 0.25mmol) was added to a 25mL Schlenk bottle in turn, and purified cyclohexane (3.0mL) was added, and placed in an oil bath at 100°C for 10h. After the reaction was over, the solvent was removed under reduced pressure, using petroleum ether/ethyl acetate as eluent, and silica gel column separation, N-(5,6,7,8-tetrakis(4-fluorophenyl)naphthalen-1-yl)pivalamide The yield was 63%. 1 H NMR(400MHz, CDCl 3 )δ7.82(d,J=6.2Hz,1H),7.48-7.43(m,2H),7.13-7.07(m,5H),6.96-6.89(m,4H), 6.68-6.65(m,2H),6.60-6.56(m,6H),0.87(s,9H); 13 C NMR(100MHz,CDCl 3 )δ176.9,161.8(d, 1 J C–F =246.7Hz), 161.6(d, 1 J C–F =244.7Hz),160.7(d, 1 J C–F =243.9Hz),160.6(d, 1 J C–F =244.2Hz),140.4,138.9,138.2,137.81, C4 = IR ( KBr ) _ _ υ(cm -1 )3444,3321,2956,2917,2848,1659,1604,1509,1478,1380,1224,1157,1093,1015,909,830,816,777,758,734; HRMS(ESI)Calcd for C 39 H 29 3 [NO26.20 M+Na] + ,found626.2088.

实施例3:N-(5,6,7,8-tetrakis(4-chlorophenyl)naphthalen-1-yl)pivalamide(3c)的合成Example 3: Synthesis of N-(5,6,7,8-tetrakis(4-chlorophenyl)naphthalen-1-yl)pivalamide (3c)

准确称取N-特戊酰基苯胺(44.3mg,0.25mmol)、二氯(环戊二烯基)合铑(III)二聚体(2.4mg,0.005mmol)、1,2-二(4-氯苯基)乙炔(123.5mg,0.5mmol)、溴化亚铜(17.9mg,0.125mmol),并依次加入到25mL的Schlenk瓶中,加入精制过的甲苯(3.0mL),置于60℃油浴中反应7h。反应结束后,减压除去溶剂,使用石油醚/乙酸乙酯作为洗脱剂,硅胶柱分离,N-(5,6,7,8-tetrakis(4-chlorophenyl)naphthalen-1-yl)pivalamide的收率为76%。1H NMR(400MHz,CDCl3)δ7.76(dd,J=5.0,3.7Hz,1H),7.44-7.43(m,2H),7.26-7.18(m,4H),7.07(dd,J=10.0,8.4Hz,4H),6.92(s,1H),6.89-6.86(m,4H),6.64(d,J=8.4Hz,2H),6.55(d,J=8.4Hz,2H),0.87(s,9H);13C NMR(100MHz,CDCl3)δ177.0,140.1,139.7,138.7,138.2,138.0,137.7,137.6,134.1,134.0,133.5,133.4,133.0,132.3,132.2,132.0,131.9,128.6,128.2,127.4,127.3,126.5,126.33,126.31,125.7,39.3,26.9;IR(KBr)υ(cm-1)3439,3326,2960,2921,2865,1653,1492,1395,1378,1092,1015,908,837,771,758,734;HRMS(ESI)Calcd for C39H29NONaCl4690.0901[M+Na]+,found690.0890.Accurately weigh N-pivaloylanilide (44.3mg, 0.25mmol), dichloro(cyclopentadienyl) rhodium(III) dimer (2.4mg, 0.005mmol), 1,2-bis(4- Chlorophenyl) acetylene (123.5mg, 0.5mmol), cuprous bromide (17.9mg, 0.125mmol), and added to a 25mL Schlenk bottle in turn, added refined toluene (3.0mL), placed in 60 ° C oil Reaction in the bath for 7h. After the reaction was over, the solvent was removed under reduced pressure, and petroleum ether/ethyl acetate was used as eluent, followed by silica gel column separation, N-(5,6,7,8-tetrakis(4-chlorophenyl)naphthalen-1-yl)pivalamide The yield was 76%. 1 H NMR (400MHz, CDCl 3 )δ7.76(dd, J=5.0,3.7Hz,1H),7.44-7.43(m,2H),7.26-7.18(m,4H),7.07(dd,J=10.0 ,8.4Hz,4H),6.92(s,1H),6.89-6.86(m,4H),6.64(d,J=8.4Hz,2H),6.55(d,J=8.4Hz,2H),0.87(s ,9H); 13 C NMR (100MHz, CDCl 3 ) δ177.0,140.1,139.7,138.7,138.2,138.0,137.7,137.6,134.1,134.0,133.5,133.4,133.0,132.3,132.2,132.0,1281.6,132.9, , 127.4, 127.3, 126.5, 126.33, 126.31, 125.7, 39.3 , 26.9; ;HRMS(ESI) Calcd for C 39 H 29 NONaCl 4 690.0901[M+Na] + ,found 690.0890.

实施例4:N-(5,6,7,8-tetrakis(4-bromophenyl)naphthalen-1-yl)pivalamide(3d)的合成Example 4: Synthesis of N-(5,6,7,8-tetrakis(4-bromophenyl)naphthalen-1-yl)pivalamide (3d)

Figure BDA0000421470320000051
Figure BDA0000421470320000051

准确称取N-特戊酰基苯胺(44.3mg,0.25mmol)、二氯(五甲基环戊二烯基)合铑(III)二聚体(3.1mg,0.005mmol)、1,2-二(4-溴苯基)乙炔(168.0mg,0.5mmol)、氧化亚铜(71.6mg,0.5mmol),并依次加入到25mL的Schlenk瓶中,加入精制过的1,4-二氧六环(3.0mL),置于80℃油浴中反应14h。反应结束后,减压除去溶剂,使用石油醚/乙酸乙酯作为洗脱剂,硅胶柱分离,N-(5,6,7,8-tetrakis(4-bromophenyl)naphthalen-1-yl)pivalamide的收率为77%。1HNMR(400MHz,CDCl3)δ7.75(dd,J=4.4,4.4Hz,1H),7.43(d,J=4.4Hz,2H),7.39(d,J=8.2Hz,2H),7.34(d,J=8.3Hz,2H),7.04-6.98(m,8H),6.90(s,1H),6.59(d,J=8.3Hz,2H),6.49(d,J=8.2Hz,2H),0.88(s,9H);13C NMR(100MHz,CDCl3)δ177.1,140.6,139.5,138.7,138.6,138.5,138.2,137.4,134.1,134.0,133.6,132.6,132.4,132.3,131.5,131.2,130.4,130.3,126.6,126.5,126.3,125.8,121.6,121.3,120.4,120.2,39.3,26.9;IR(KBr)υ(cm-1)3438,3329,2956,2924,2854,1654,1489,1391,1101,1071,1011,908,827,774,764,732;HRMS(ESI)Calcd forC39H29NONaBr4865.8880[M+Na]+,found865.8846.Accurately weigh N-pivaloylanilide (44.3mg, 0.25mmol), dichloro(pentamethylcyclopentadienyl) rhodium(III) dimer (3.1mg, 0.005mmol), 1,2-di (4-Bromophenyl)acetylene (168.0mg, 0.5mmol), cuprous oxide (71.6mg, 0.5mmol), and added to a 25mL Schlenk bottle in turn, added refined 1,4-dioxane ( 3.0mL), placed in an 80°C oil bath for 14h. After the reaction was over, the solvent was removed under reduced pressure, using petroleum ether/ethyl acetate as eluent, and silica gel column separation, N-(5,6,7,8-tetrakis(4-bromophenyl)naphthalen-1-yl)pivalamide The yield was 77%. 1 HNMR(400MHz, CDCl 3 )δ7.75(dd, J=4.4,4.4Hz,1H),7.43(d,J=4.4Hz,2H),7.39(d,J=8.2Hz,2H),7.34( d,J=8.3Hz,2H),7.04-6.98(m,8H),6.90(s,1H),6.59(d,J=8.3Hz,2H),6.49(d,J=8.2Hz,2H), 0.88(s,9H); 13 C NMR(100MHz,CDCl 3 )δ177.1,140.6,139.5,138.7,138.6,138.5,138.2,137.4,134.1,134.0,133.6,132.6,132.4,132.3,131.5,130.4, 130.3,126.6,126.5,126.3,125.8,121.6,121.3,120.4,120.2,39.3,26.9; IR(KBr)υ(cm -1 )3438,3329,2956,2924,2854,1654,1489,1391,1101, 1071,1011,908,827,774,764,732; HRMS (ESI) Calcd for C 39 H 29 NONaBr 4 865.8880[M+Na] + ,found 865.8846.

实施例5:N-(5,6,7,8-tetra-p-tolylnaphthalen-1-yl)pivalamide(3e)的合成Example 5: Synthesis of N-(5,6,7,8-tetra-p-tolylnaphthalen-1-yl)pivalamide (3e)

Figure BDA0000421470320000052
Figure BDA0000421470320000052

准确称取N-特戊酰基苯胺(44.3mg,0.25mmol)、三(三苯基膦)氯化铑(I)(10.0mg,0.025mmol)、1,2-二(4-甲苯基)乙炔(103.2mg,0.5mmol)、氯化铜(100.9mg,0.75mmol),并依次加入到25mL的Schlenk瓶中,加入精制过的二甲基亚砜(3.0mL),置于120℃油浴中反应30h。反应结束后,减压除去溶剂,使用石油醚/乙酸乙酯作为洗脱剂,硅胶柱分离,N-(5,6,7,8-tetra-p-tolylnaphthalen-1-yl)pivalamide(3e)的收率为67%。1H NMR(400MHz,CDCl3)δ7.88(d,J=6.7Hz,1H),7.44(d,J=8.4Hz,1H),7.34(dd,J=7.8,8.2Hz,1H),7.06-6.96(m,9H),6.62-6.59(m,6H),6.49(d,J=7.9Hz,2H),2.29(s,3H),2.26(s,3H),2.09(s,3H),2.07(s,3H),0.81(s,9H);13C NMR(100MHz,CDCl3)δ177.0,141.5,139.4,139.20,139.17,137.7,137.4,137.1,136.6,135.8,134.44,134.37,134.30,134.25,133.5,131.2,131.1,131.0,129.1,128.3,127.3,127.2,125.43,125.38,124.2,39.3,26.9,21.4,21.3,21.2;IR(KBr)υ(cm-1)3421,3022,2956,2923,2868,1670,1510,1466,1378,1157,1110,1021,817,756,744;HRMS(ESI)Calcd forC43H41NONa610.3086[M+Na]+,found610.3094.Accurately weigh N-pivaloylanilide (44.3mg, 0.25mmol), tris(triphenylphosphine) rhodium(I) chloride (10.0mg, 0.025mmol), 1,2-bis(4-tolyl)acetylene (103.2mg, 0.5mmol), copper chloride (100.9mg, 0.75mmol), and added to a 25mL Schlenk bottle in turn, added refined dimethyl sulfoxide (3.0mL), placed in an oil bath at 120°C Reaction 30h. After the reaction, the solvent was removed under reduced pressure, using petroleum ether/ethyl acetate as the eluent, and separated on a silica gel column, N-(5,6,7,8-tetra-p-tolylnaphthalen-1-yl)pivalamide (3e) The yield is 67%. 1 H NMR (400MHz, CDCl 3 ) δ7.88 (d, J=6.7Hz, 1H), 7.44 (d, J=8.4Hz, 1H), 7.34 (dd, J=7.8, 8.2Hz, 1H), 7.06 -6.96(m,9H),6.62-6.59(m,6H),6.49(d,J=7.9Hz,2H),2.29(s,3H),2.26(s,3H),2.09(s,3H), 2.07(s,3H),0.81(s,9H); 13 C NMR(100MHz,CDCl 3 )δ177.0,141.5,139.4,139.20,139.17,137.7,137.4,137.1,136.6,135.8,134.44,134.37,134.325,13 ,133.5,131.2,131.1,131.0,129.1,128.3,127.3,127.2,125.43,125.38,124.2,39.3,26.9,21.4,21.3,21.2;IR(KBr)υ(cm -1 )3421,3022,2956,2923 ,2868,1670,1510,1466,1378,1157,1110,1021,817,756,744; HRMS (ESI) Calcd for C 43 H 41 NONa610.3086[M+Na] + ,found610.3094.

实施例6:N-(3-methyl-5,6,7,8-tetraphenylnaphthalen-1-yl)pivalamide(3f)的合成Example 6: Synthesis of N-(3-methyl-5,6,7,8-tetraphenylnaphthalen-1-yl)pivalamide (3f)

准确称取N-特戊酰基-3-甲基苯胺(47.8mg,0.25mmol)、氯化铑(2.6mg,0.0125mmol)、二苯乙炔(89.2mg,0.5mmol)、醋酸铜(45.5mg,0.25mmol),并依次加入到25mL的Schlenk瓶中,加入精制过的乙醇(3.0mL),置于70℃油浴中反应9h。反应结束后,减压除去溶剂,使用石油醚/乙酸乙酯作为洗脱剂,硅胶柱分离,N-(3-methyl-5,6,7,8-tetraphenylnaphthalen-1-yl)pivalamide的收率为79%。1H NMR(400MHz,CDCl3)δ7.81(s,1H),7.25–7.13(m,12H),6.81–6.73(m,8H),6.63–6.61(m,2H),2.38(s,3H),0.80(s,9H);13C NMR(100MHz,CDCl3)δ177.0,142.2,140.6,140.4,140.0,139.0,138.8,135.6,134.24,134.17,133.3,131.3,131.1,128.3,127.6,127.1,126.5,126.4,125.34,125.29,125.14,125.06,124.6,124.5,123.6,39.3,26.9,21.7;IR(KBr)υ(cm-1)3421,3343,2955,2923,1669,1507,1494,1457,1441,1400,1165,1071,1027,858,757,735,698;HRMS(ESI)Calcd forC40H35NONa568.2616[M+Na]+,found568.2615.Accurately weigh N-pivaloyl-3-methylaniline (47.8mg, 0.25mmol), rhodium chloride (2.6mg, 0.0125mmol), toluene (89.2mg, 0.5mmol), copper acetate (45.5mg, 0.25mmol), and sequentially added to a 25mL Schlenk bottle, added refined ethanol (3.0mL), and placed in an oil bath at 70°C for 9h. After the reaction was over, the solvent was removed under reduced pressure, and petroleum ether/ethyl acetate was used as the eluent, and the silica gel column separation, the yield of N-(3-methyl-5,6,7,8-tetraphenylnaphthalen-1-yl)pivalamide 79%. 1 H NMR (400MHz, CDCl 3 )δ7.81(s,1H),7.25–7.13(m,12H),6.81–6.73(m,8H),6.63–6.61(m,2H),2.38(s,3H ),0.80(s,9H); 13 C NMR(100MHz,CDCl 3 )δ177.0,142.2,140.6,140.4,140.0,139.0,138.8,135.6,134.24,134.17,133.3,131.3,131.1,128.3,1277.6,12 126.5,126.4,125.34,125.29,125.14,125.06,124.6,124.5,123.6,39.3,26.9,21.7; IR(KBr)υ(cm -1 )3421,3343,2955,2923,1669,1507,1494,1457, 1441,1400,1165,1071,1027,858,757,735,698; HRMS (ESI) Calcd for C 40 H 35 NONa568.2616[M+Na] + ,found568.2615.

实施例7:N-(3-chloro-5,6,7,8-tetraphenylnaphthalen-1-yl)pivalamide(3g)的合成Example 7: Synthesis of N-(3-chloro-5,6,7,8-tetraphenylnaphthalen-1-yl)pivalamide (3g)

Figure BDA0000421470320000062
Figure BDA0000421470320000062

准确称取N-特戊酰基-3-氯苯胺(52.9mg,0.25mmol)、醋酸铑(1.1mg,0.0025mmol)、1,2-二(4-氟苯基)乙炔(107.0mg,0.5mmol)、碘化亚铜(47.6mg,0.25mmol),并依次加入到25mL的Schlenk瓶中,加入精制过的环己烷(3.0mL),置于110℃油浴中反应7h。反应结束后,减压除去溶剂,使用石油醚/乙酸乙酯作为洗脱剂,硅胶柱分离,N-(3-chloro-5,6,7,8-tetraphenylnaphthalen-1-yl)pivalamide的收率为78%。1H NMR(400MHz,CDCl3)δ8.10(d,J=2.0Hz,1H),7.43(d,J=2.1Hz,1H),7.38(s,1H),7.24–7.13(m,10H),6.82–6.78(m,6H),6.74–6.72(m,2H),6.62–6.60(m,2H),0.78(s,9H);13C NMR(100MHz,CDCl3)δ177.0,141.6,141.5,140.2,140.1,140.0,139.2,138.9,135.2,134.8,134.5,131.8,131.3,131.2,131.0,128.7,127.9,127.6,127.0,126.8,126.6,125.7,125.4,123.9,123.9,123.7,123.4,39.5,27.0;IR(KBr)υ(cm-1)3417,3335,3057,3025,2963,2928,2869,1673,1598,1493,1455,1441,1376,1347,1245,1158,1027,909,861,733,698;HRMS(ESI)Calcd for C39H33NOCl566.2251[M+H]+,found566.2300.Accurately weigh N-pivaloyl-3-chloroaniline (52.9mg, 0.25mmol), rhodium acetate (1.1mg, 0.0025mmol), 1,2-di(4-fluorophenyl)acetylene (107.0mg, 0.5mmol ), cuprous iodide (47.6mg, 0.25mmol), and sequentially added to a 25mL Schlenk bottle, added refined cyclohexane (3.0mL), and placed in an oil bath at 110°C for 7h. After the reaction was over, the solvent was removed under reduced pressure, and petroleum ether/ethyl acetate was used as the eluent, and the silica gel column separation, the yield of N-(3-chloro-5,6,7,8-tetraphenylnaphthalen-1-yl)pivalamide 78%. 1 H NMR (400MHz, CDCl 3 ) δ8.10(d, J=2.0Hz, 1H), 7.43(d, J=2.1Hz, 1H), 7.38(s, 1H), 7.24–7.13(m, 10H) ,6.82–6.78(m,6H),6.74–6.72(m,2H),6.62–6.60(m,2H),0.78(s,9H); 13 C NMR(100MHz,CDCl 3 )δ177.0,141.6,141.5, 140.2,140.1,140.0,139.2,138.9,135.2,134.8,134.5,131.8,131.3,131.2,131.0,128.7,127.9,127.6,127.0,126.8,126.6,125.7,125.4,123.9,123.9,123.7,123.4,39.5, ( ESI) Calcd for C 39 H 33 NOCl566.2251[M+H] + ,found566.2300.

实施例8:N-(5,6,7,8-tetraphenylnaphthalen-1-yl)acetamide(3h)的合成Example 8: Synthesis of N-(5,6,7,8-tetraphenylnaphthalen-1-yl)acetamide (3h)

Figure BDA0000421470320000071
Figure BDA0000421470320000071

准确称取N-特戊酰基苯胺(33.8mg,0.25mmol)、二氯(环戊二烯基)合铑(III)二聚体(2.4mg,0.005mmol)、1,2-二(4-氯苯基)乙炔(123.5mg,0.5mmol)、溴化亚铜(17.9mg,0.125mmol),并依次加入到25mL的Schlenk瓶中,加入精制过的甲苯(3.0mL),置于90℃油浴中反应8h。反应结束后,减压除去溶剂,使用石油醚/乙酸乙酯作为洗脱剂,硅胶柱分离,N-(5,6,7,8-tetraphenylnaphthalen-1-yl)acetamide的收率为23%。1H NMR(CDCl3,400MHz)δ7.94(d,J=7.4Hz,1H),7.50(d,J=8.5Hz,1H),7.38(dd,J=7.8,8.2Hz,1H),7.24-7.17(m,10H),7.00(s,1H),6.82-6.73(m,10H),1.39(s,3H);13C NMR(CDCl3,100MHz)δ168.3,142.4,141.1,140.3,140.1,139.8,139.6,139.0,134.6,133.9,133.1,131.3,131.1,130.7,128.4,127.7,127.2,126.7,126.6,126.0,125.54,125.45,124.5,123.5,24.1.Accurately weigh N-pivaloylanilide (33.8 mg, 0.25 mmol), dichloro(cyclopentadienyl) rhodium (III) dimer (2.4 mg, 0.005 mmol), 1,2-bis(4- Chlorophenyl) acetylene (123.5mg, 0.5mmol), cuprous bromide (17.9mg, 0.125mmol), and added to a 25mL Schlenk bottle in turn, added refined toluene (3.0mL), placed in 90 ° C oil Reaction in the bath for 8h. After the reaction, the solvent was removed under reduced pressure, and petroleum ether/ethyl acetate was used as the eluent, and silica gel column separation was performed. The yield of N-(5,6,7,8-tetraphenylnaphthalen-1-yl)acetamide was 23%. 1 H NMR(CDCl 3 ,400MHz)δ7.94(d,J=7.4Hz,1H),7.50(d,J=8.5Hz,1H),7.38(dd,J=7.8,8.2Hz,1H),7.24 -7.17(m,10H),7.00(s,1H),6.82-6.73(m,10H),1.39(s,3H); 13 C NMR(CDCl 3 ,100MHz)δ168.3,142.4,141.1,140.3,140.1, 139.8, 139.6, 139.0, 134.6, 133.9, 133.1, 131.3, 131.1, 130.7, 128.4, 127.7, 127.2, 126.7, 126.6, 126.0, 125.54, 125.45, 124.5, 123.5, 24.1.

实施例9:N-(5,6,7,8-tetraphenylnaphthalen-1-yl)adamantane-1-carboxamide(3i)的合成Example 9: Synthesis of N-(5,6,7,8-tetraphenylnaphthalen-1-yl)adamantane-1-carboxamide (3i)

Figure BDA0000421470320000072
Figure BDA0000421470320000072

准确称取N-金刚烷甲酰基苯胺(63.8mg,0.25mmol)、二氯(五甲基环戊二烯基)合铑(III)二聚体(3.1mg,0.005mmol)、1,2-二(4-溴苯基)乙炔(168.0mg,0.5mmol)、氧化亚铜(71.6mg,0.5mmol),并依次加入到25mL的Schlenk瓶中,加入精制过的1,4-二氧六环(3.0mL),置于100℃油浴中中反应12h。反应结束后,减压除去溶剂,使用石油醚/乙酸乙酯作为洗脱剂,硅胶柱分离,N-(5,6,7,8-tetraphenylnaphthalen-1-yl)adamantane-1-carboxamide的收率为76%。1H NMR(400MHz,CDCl3)δ7.96(d,J=7.5Hz,1H),7.48(d,J=8.5Hz,1H),7.39(dd,J=8.2,7.7Hz,1H),7.29(s,1H),7.24–7.14(m,10H),6.81–6.74(m,8H),6.64–6.62(m,2H),1.86(s,3H),1.65–1.51(m,6H),1.39(s,6H);13C NMR(100MHz,CDCl3)δ176.5,142.3,141.4,140.5,140.4,140.0,139.5,139.0,134.4,134.2,133.5,131.31,131.29,131.1,128.6,127.7,127.1,126.7,126.5,125.8,125.5,125.4,125.3,125.2,124.5,41.2,38.1,36.4,28.1;IR(KBr)υ(cm-1)3422,3056,3023,2953,2923,2850,1678,1599,1492,1467,1441,1379,1346,1250,1220,1110,1072,910,778,734,697;HRMS(ESI)Calcd for C45H39NONa632.2929[M+Na]+,found632.2921.Accurately weigh N-adamantanecarboxanilide (63.8 mg, 0.25 mmol), dichloro(pentamethylcyclopentadienyl) rhodium (III) dimer (3.1 mg, 0.005 mmol), 1,2- Bis(4-bromophenyl)acetylene (168.0mg, 0.5mmol) and cuprous oxide (71.6mg, 0.5mmol) were successively added to a 25mL Schlenk bottle, and refined 1,4-dioxane was added (3.0 mL), placed in an oil bath at 100°C for 12 h. After the reaction, the solvent was removed under reduced pressure, using petroleum ether/ethyl acetate as the eluent, and separated on a silica gel column, the yield of N-(5,6,7,8-tetraphenylnaphthalen-1-yl)adamantane-1-carboxamide 76%. 1 H NMR (400MHz, CDCl 3 )δ7.96(d, J=7.5Hz, 1H), 7.48(d, J=8.5Hz, 1H), 7.39(dd, J=8.2, 7.7Hz, 1H), 7.29 (s,1H),7.24–7.14(m,10H),6.81–6.74(m,8H),6.64–6.62(m,2H),1.86(s,3H),1.65–1.51(m,6H),1.39 (s,6H); 13 C NMR(100MHz,CDCl 3 )δ176.5,142.3,141.4,140.5,140.4,140.0,139.5,139.0,134.4,134.2,133.5,131.31,131.29,131.1,128.6,127.1,127 , 126.5, 125.8 , 125.5, 125.4, 125.3, 125.2, 124.5, 41.2, 38.1, 36.4, 28.1; ,1467,1441,1379,1346,1250,1220,1110,1072,910,778,734,697; HRMS (ESI) Calcd for C 45 H 39 NONa632.2929[M+Na] + ,found632.2921.

Claims (8)

1.一种多取代稠环类化合物的制备方法,其特征在于,以N-酰基芳胺和内炔为原料、铑盐为催化剂、铜盐为氧化剂,在有机溶剂中加热反应,合成一系列多取代稠环类化合物,反应式如下:1. A kind of preparation method of substituted condensed ring compound is characterized in that, taking N-acyl arylamine and internal alkyne as raw material, rhodium salt as catalyzer, copper salt as oxidant, heating reaction in organic solvent, synthesizes a series of Multi-substituted fused ring compounds, the reaction formula is as follows:
Figure FDA0000421470310000011
Figure FDA0000421470310000011
式中:In the formula: R为烷基、芳基;R is an alkyl group or an aryl group; R1为氢、烷基、芳基、烷氧基、酯基、酰基、氰基、卤素; R is hydrogen, alkyl, aryl, alkoxy, ester, acyl, cyano, halogen; R2和R3为烷基、烯基、炔基、芳基。R 2 and R 3 are alkyl, alkenyl, alkynyl, aryl.
2.根据权利要求1所述的制备方法,其特征在于,所述铑盐催化剂是三氯化铑、醋酸铑、二氯(环戊二烯基)合铑(III)二聚体、二氯(五甲基环戊二烯基)合铑(III)二聚体、三(三苯基膦)氯化铑(I),其中,铑盐的加入量为N-酰基芳胺的1-20mol%。2. preparation method according to claim 1, is characterized in that, described rhodium salt catalyst is rhodium trichloride, rhodium acetate, dichloro (cyclopentadienyl) rhodium (III) dimer, dichloro (Pentamethylcyclopentadienyl) rhodium (III) dimer, three (triphenylphosphine) rhodium chloride (I), wherein, the addition of rhodium salt is 1-20mol of N-acyl arylamine %. 3.根据权利要求书1或2所述的制备方法,其特征在于,所述铜盐氧化剂是碘化亚铜、溴化亚铜、氯化亚铜、氧化亚铜、醋酸铜、一水合醋酸铜、氯化铜或氧化铜,其中,铜盐的加入量为N-酰基芳胺的20mol%-400mol%。3. according to the preparation method described in claim 1 or 2, it is characterized in that, described copper salt oxidizing agent is cuprous iodide, cuprous bromide, cuprous chloride, cuprous oxide, copper acetate, acetic acid monohydrate Copper, copper chloride or copper oxide, wherein the amount of copper salt added is 20mol%-400mol% of the N-acyl arylamine. 4.根据权利要求1或2所述的制备方法,其特征在于,所述有机溶剂是苯、甲苯、1,4-二氧六环、二甲基亚砜、N,N-二甲基甲酰胺、甲醇、乙醇、异丙醇、正丁醇、二氯甲烷、三氯甲烷、正丁醚、四氯化碳、乙酸乙酯、石油醚、甲基叔丁基醚、四氢呋喃、丙酮或乙腈中的一种或两种以上的混合溶剂;所述有机溶剂的加入量为N-酰基芳胺质量的10-100倍。4. The preparation method according to claim 1 or 2, characterized in that, the organic solvent is benzene, toluene, 1,4-dioxane, dimethyl sulfoxide, N,N-dimethylmethane Amide, methanol, ethanol, isopropanol, n-butanol, methylene chloride, chloroform, n-butyl ether, carbon tetrachloride, ethyl acetate, petroleum ether, methyl tert-butyl ether, tetrahydrofuran, acetone, or acetonitrile One or two or more mixed solvents; the amount of the organic solvent added is 10-100 times the mass of the N-acyl arylamine. 5.根据权利要求3所述的制备方法,其特征在于,所述有机溶剂是苯、甲苯、1,4-二氧六环、二甲基亚砜、N,N-二甲基甲酰胺、甲醇、乙醇、异丙醇、正丁醇、二氯甲烷、三氯甲烷、正丁醚、四氯化碳、乙酸乙酯、石油醚、甲基叔丁基醚、四氢呋喃、丙酮或乙腈中的一种或两种以上的混合溶剂;所述有机溶剂的加入量为N-酰基芳胺质量的10-100倍。5. preparation method according to claim 3 is characterized in that, described organic solvent is benzene, toluene, 1,4-dioxane, dimethylsulfoxide, N, N-dimethylformamide, Methanol, ethanol, isopropanol, n-butanol, methylene chloride, chloroform, n-butyl ether, carbon tetrachloride, ethyl acetate, petroleum ether, methyl tert-butyl ether, tetrahydrofuran, acetone, or acetonitrile One or more than two mixed solvents; the amount of the organic solvent added is 10-100 times the mass of the N-acyl arylamine. 6.根据权利要求1、2或5所述的制备方法,其特征在于所述反应温度为50–130℃。6. The preparation method according to claim 1, 2 or 5, characterized in that the reaction temperature is 50-130°C. 7.根据权利要求3所述的制备方法,其特征在于所述反应温度为50–130℃。7. The preparation method according to claim 3, characterized in that the reaction temperature is 50-130°C. 8.根据权利要求4所述的制备方法,其特征在于所述反应温度为50–130℃。8. The preparation method according to claim 4, characterized in that the reaction temperature is 50-130°C.
CN201310604451.1A 2013-11-25 2013-11-25 Preparation method of multi-substituted fused ring compounds Pending CN103664674A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310604451.1A CN103664674A (en) 2013-11-25 2013-11-25 Preparation method of multi-substituted fused ring compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310604451.1A CN103664674A (en) 2013-11-25 2013-11-25 Preparation method of multi-substituted fused ring compounds

Publications (1)

Publication Number Publication Date
CN103664674A true CN103664674A (en) 2014-03-26

Family

ID=50303562

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310604451.1A Pending CN103664674A (en) 2013-11-25 2013-11-25 Preparation method of multi-substituted fused ring compounds

Country Status (1)

Country Link
CN (1) CN103664674A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106883152A (en) * 2017-04-07 2017-06-23 上海应用技术大学 A kind of preparation method of β amino ketones
CN107118196A (en) * 2017-06-06 2017-09-01 安徽师范大学 The preparation method of different coumarin derivative
CN114044771A (en) * 2021-10-18 2022-02-15 成都大学 Compound with 5-hydroxyfuran-2(5H)-one skeleton and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102775325A (en) * 2012-08-23 2012-11-14 北京科技大学 Pyrene symmetric disk-like compound and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102775325A (en) * 2012-08-23 2012-11-14 北京科技大学 Pyrene symmetric disk-like compound and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JUNLIANG WU等: "Palladium catalyzed synthesis of highly substituted naphthalenes via direct ring construction from amides with alkynes", 《CHEM. COMMUN.》, vol. 46, 31 December 2010 (2010-12-31) *
NOBUYOSHI UMEDA等: "Fluorescent Naphthyl- and Anthrylazoles from the Catalytic Coupling of Phenylazoles with Internal Alkynes through the Cleavage of Multiple C_H Bonds", 《ANGEW. CHEM. INT. ED.》, vol. 47, 31 December 2008 (2008-12-31) *
ZHUANGZHI SHI等: "A Palladium-Catalyzed Oxidative Cycloaromatization of Biaryls with Alkynes Using Molecular Oxygen as the Oxidant", 《ANGEW. CHEM. INT. ED.》, vol. 48, 31 December 2009 (2009-12-31), pages 7895 - 7898 *
杨定乔等: "过渡金属不对称催化氧杂苯并降冰片烯开环反应的研究进展", 《有机化学》, no. 12, 25 December 2006 (2006-12-25) *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106883152A (en) * 2017-04-07 2017-06-23 上海应用技术大学 A kind of preparation method of β amino ketones
CN107118196A (en) * 2017-06-06 2017-09-01 安徽师范大学 The preparation method of different coumarin derivative
CN107118196B (en) * 2017-06-06 2019-07-19 安徽师范大学 Preparation method of isocoumarin derivatives
CN114044771A (en) * 2021-10-18 2022-02-15 成都大学 Compound with 5-hydroxyfuran-2(5H)-one skeleton and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101798279B (en) Method for preparing iron-catalyzed pyrrole and pyrrole cyclic compounds
CN103553857B (en) A kind of method preparing o-trifluoromethyl aniline or derivatives thereof
CN103664674A (en) Preparation method of multi-substituted fused ring compounds
CN106831283A (en) A kind of method of the iodo alkynes of high selectivity 1
CN102911105B (en) 3-aroyl indole compound synthesis method
CN110003081B (en) Synthesis method of polyfluoroalkyl-substituted indoline and tetrahydroisoquinoline
CN107935925B (en) Preparation method of polysubstituted phenanthridine compound
CN103664821B (en) A kind of benzothiazole compound preparation method based near amino thiophenols cyclisation
CN107641068A (en) A kind of preparation method of indone analog derivative
CN107746392A (en) A kind of preparation method of the oxazole alkyl compound containing caged scaffold
CN109369647B (en) A kind of synthetic method of fused ring [1,2-a]indole compound and 2,3-disubstituted indole compound
CN102659658A (en) Method for synthesis of highly functionalized pyrrole compound
CN110183341A (en) 1,2- dicarbapentaborane class compound and its synthetic method
CN106883188B (en) 5-hydrogen-1, 4-benzodiazepine compound and synthesis method thereof
Dacko et al. Synthesis of tryptophan derivatives via a palladium-catalyzed N-heteroannulation
CN107098844B (en) A kind of synthetic method for the acyl indol quinoline class compound that C-5 nitro replaces
CN103910682B (en) A kind of benzimidazoles compound preparation method based on O-Phenylene Diamine cyclisation
CN104529684B (en) The method of functional group's ortho position iodate on palladium/carbon catalysis aromatic ring
CN106366035A (en) Method for synthesizing quinoline derivative
CN107056674A (en) A kind of method of suzuki cyclisation coupling one-step synthesis dihydro pyrrole derivates
CN107082763A (en) A kind of method for synthesizing indazole ketone compounds
CN104262357B (en) A kind of preparation method of 7-chloro-6H-benzothiopyran [4,3-b] quinoline and derivatives thereof
CN107151226A (en) A kind of preparation method of polysubstituted isoindolinone
Mori et al. Formation of Seven-Membered-Ring Fused Bithiophene Derivatives by Nosyl Annulation
CN115197135B (en) A zinc-catalyzed method for preparing multi-substituted quinoline compounds

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140326